Market Dashboard
- You are here:
- Home
- Markets
- Market Dashboard
- Strides Pharma Science Ltd.
NSE Symbol: | BSE Code: | ISIN: | Sector:
- Add to Portfolio
- Add to Watchlist
- Add to Alert
- Add to Message
Add to Portfolio
NSE
488.00
| Change | Change % |
| -7.80 | -1.57% |
Updated:30 Nov, 2023, 09:07 AM IST |
|
BSE
489.35
| Change | Change % |
| -6.75 | -1.36% |
Updated:30 Nov, 2023, 09:21 AM IST |
|
Previous Close
Day's Open
Volume Traded (in 000's)
Value Traded (in Cr)
Day's Range
485.50491.80
52 Wk Range
340.00 550.40
Compare Price performance of vs. Peer Companies
From sector
Compare with Peers on Key Fundamentals and Financials
- SUNPHARMA
1.29% - DIVISLAB
0.05% - CIPLA
0.74% - DRREDDY
1.69% - CADILAHC
0.70% - AUROPHARMA
1.22% - LUPIN
0.88% - ALKEM
0.38% - ABBOTINDIA
-0.89% - TORNTPHARM
0.54% - BIOCON
1.65% - GLAXO
-0.02% - GLENMARK
0.96% - SANOFI
0.21% - PFIZER
-0.51% - PEL
1.85% - AJANTPHARM
1.58% - APLLTD
11.28% - NATCOPHARM
1.13% - IPCALAB
2.27% - ERIS
0.08% - ASTRAZEN
-0.79% - JBCHEPHARM
2.47% - GRANULES
4.62% - CAPLINLABS
0.55% - MERCK
-1.07% - FDC
-0.43% - NEULANDLAB
-0.44% - MARKSANS
11.97% - STAR
-1.36%
's Latest Research Report
| Brokerage/Analyst | Report Date | Call | Price@Call | Target | Current Status | Report |
|---|---|---|---|---|---|---|
| Motilal Oswal - |
01-02-2020 | Buy | 461.15 | 550.00 | Closed | Details |
| Credit Suisse - |
19-05-2017 | Buy | 987.55 | 1185.00 | Closed | Details |
| Religare - |
01-11-2016 | Hold | 1051.25 | 1190.00 | Target Hit | Details |
| Religare - |
18-08-2016 | Hold | 1023.35 | 1130.00 | Target Hit | Details |
| Nirmal Bang - |
04-07-2016 | Buy | 1176.50 | 1234.00 | Target Hit | Details |
More from Research Reports »
Strides Pharma Scien's Key Fundamentals
| Parameter | Values |
|---|---|
| Market Cap (in ₹ Cr.) | 4,370.02 |
| Earning Per Share (EPS TTM) (₹) | 12.33 |
| Price To Earnings (P/E) Ratio | 39.58 |
| Book Value Per Share (₹) | 352.29 |
| Price To Books (P/B) Ratio | 1.39 |
| EBIT Margin (%) | 67.89 |
| PAT Margin (%) | 60.67 |
| ROCE (%) | 23.18 |
| PAT Growth (%) | 721.46 |
| Total Debt to Equity (D/E) Ratio | 0.19 |
More from Key Fundamentals »
Strides Pharma Scien's Financial Summary
| Parameter | MAR'18 (₹ Cr.) |
MAR'17 (₹ Cr.) |
YoY %Change |
|---|---|---|---|
| Balance Sheet: | |||
| Share Capital | 89.50 | 89.42 | 0.09% |
| Total Non-Current Liabilities | -34.41 | 795.22 | -104.33% |
| Total Current Liabilities | 1,104.05 | 1,434.16 | -23.02% |
| Total Liabilities | 4,231.65 | 5,461.90 | -22.52% |
| Total Non-Current Assets | 2,732.11 | 2,882.74 | -5.23% |
| Currents Investments | 311.48 | 1,279.54 | -75.66% |
| Cash and Bank | 79.79 | 94.92 | -15.94% |
| Total Current Assets Excluding Current Investments | 1,188.06 | 1,299.62 | -8.58% |
| Total Assets | 4,231.65 | 5,461.90 | -22.52% |
| Profit and Loss: | |||
| Gross Sales | 1,469.61 | 1,381.82 | 6.35% |
| Net Sales | 1,469.61 | 1,381.82 | 6.35% |
| PBIDT (Excl OI) | 104.91 | 111.97 | -6.31% |
| PAT | 891.59 | 108.54 | 721.46% |
More from Financial Summary »
Strides Pharma Scien's Shareholding Pattern
| Description | Percent of Share (%) |
|---|---|
| Promoters | 28.35 |
| Individuals | 8.59 |
| Institutions | 16.40 |
| FII | 39.15 |
| Govt. | 0.00 |
| Others | 7.51 |
More from Holding Pattern »
Strides Pharma Scien held by Mutual Fund Schemes
More from Mutual Fund Holding »
's Futures and Options Quotes
| Contract Expiry Date |
Type | Current price | Change | Change % | Premium / Discount |
|---|---|---|---|---|---|
| No Records Found! | |||||
More from Futures and Options Quotes »
..